- Library Home /
- Search Collections /
- Open Collections /
- Browse Collections /
- UBC Theses and Dissertations /
- Prevention of ischemia-induced arrhythmias in the rat...
Open Collections
UBC Theses and Dissertations
UBC Theses and Dissertations
Prevention of ischemia-induced arrhythmias in the rat : a comparative study of ester-linked RSD compounds with their amide-linked analogues Wang, Wei-Qun
Abstract
These studies were intended to investigate the in vivo cardiac electrophysiological and antiarrhythmic activities of a related series of RSD compounds, which included ester-linked compounds (RSD973, RSD1009, RSD1046) and their amide-linked analogues (RSD996, RSD997, RSD1044). Special emphasis was placed on a comparison of their selectivity for myocardial ischemia-induced arrhythmias. The regional ischemia model used was ligation of a branch of left coronary artery in anesthetized rats. Antiarrhythmic activity was expressed as effects on incidence, severity and duration of ventricular arrhythmias, including premature ventricular beats (PVBs), ventricular tachycardia (VT) and ventricular fibrillation (VF). A dose-response curve for antiarrhythmic activity was constructed by plotting the percent change in arrhythmia score, from control value, versus log-m dose. The effective dose producing 50% protection (ED₅₀) was calculated from the dose-response curves. The results showed that all compounds studied were protective against ischemiainduced arrhythmias in a dose-dependent manner. At sufficiently high doses, these compounds completely abolished VT or VF and markedly reduced PVB. The mortality caused by sustained VT or VF was also significantly reduced. There were no obvious similarities in antiarrhythmic effectiveness among the different pairs of ester and amide compounds with respect to antiarrhythmic dose-response curves. However, antiarrhythmic dose-response curve analyses showed that esters RSD973 and RSD1009 had antiarrhythmic effectiveness similar to that of their corresponding amide analogues RSD996 and RSD997, respectively, in terms of efficacy, potency and curve slope. The antiarrhythmic dose-response curve for the ester RSD1046 was parallel to that for its amide analogue RSD1044 with a right shift (i.e. lower potency). The results suggested that the underlying mechanisms for the antiarrhymic effects of esters and corresponding amide analogues might be the same, although the exact mechanisms remain unclear. The effects of ester and amide analogues on haemodynamic and electrocardiographic (ECG) parameters in the absence of myocardial ischemia were investigated. In addition, electrical stimulation was applied to the heart to examine drug effects on cardiac tissue excitability and refractoriness. Cumulative dose-response curves were constructed and the potencies were expressed as D₂₅values (i.e. effective dose producing 25% change from predrug value). Both ester and amide compounds decreased blood pressure (BP) and heart rate (HR) in a dose-dependent manner. The ester-linked compounds were less potent for effects on blood pressure and heart rate than their amide-linked analogues. In most cases, a maximal response (efficacy) could not be obtained while the slopes of dose-response curves did not differ between ester and amide analogues. According to their effects on the ECG and electrical stimulation variables, the compounds could possess both sodium (Na⁺) and potassium (K⁺) channel blocking activities. Prolongation of PR and QRS intervals of ECG, and increase in iT and VF-VTt of electrical stimulation were considered to be mainly attributable to Na⁺ channel blockade, while prolongation of QT interval, increase in ERP and decrease in MFF to be mainly attributable to K⁺ channel blockade. RSD compounds influenced most of these indicators in a dose-dependent fashion. Ester analogues appeared to be less potent for the effects on indicators than their corresponding amide analogues, although it was not possible to establish this conclusion statistically for all the different indicators. Comparison (by ratios) of potencies for indicators of Na+ channel blockade (PR, iT) to those for indicators of K⁺ channel blockade (QT, ERP) suggested no preference for Na+ or K⁺ blockade between ester and amide analogues. Finally, in order to evaluate selectivity for antiarrhythmic effects on arrhythmias induced by myocardial ischemia, therapeutic indices were estimated from the ratio of D25 values for BP, HR, ECG and electrical stimulation to the ED5 0 for antiarrhythmic activity. The morpholino esters RSD973 and RSD1009 had higher therapeutic indices, especially for those indices related to the ECG, than their amide analogues RSD996 and RSD997. However, for the corresponding dimethoxy pair, RSD1046 failed to show higher therapeutic indices than its amide analogue RSD1044, due to its lower potencies for both antiarrhythmic activity as well as electrophysiological effects on normal cardiac tissue. Such results suggest that the ester or amide group on morpholino compounds might be involved in the selectivity for myocardial ischemia-induced arrhythmias through interaction with other molecular moieties. The tentative suggestion drawn from this study, that ester-linked compounds with certain molecular structures provide wider safety margin with less haemodynamic depression, less bradycardiac effect and less potential proarrhythmic activity than their amide-linked analogues, needs to be confirmed in a larger series (at least twice the size of the present series) of structurally complementary compounds. The underlying mechanisms of action of the esters and amides remain to be elucidated.
Item Metadata
Title |
Prevention of ischemia-induced arrhythmias in the rat : a comparative study of ester-linked RSD compounds with their amide-linked analogues
|
Creator | |
Publisher |
University of British Columbia
|
Date Issued |
1999
|
Description |
These studies were intended to investigate the in vivo cardiac
electrophysiological and antiarrhythmic activities of a related series of RSD
compounds, which included ester-linked compounds (RSD973, RSD1009,
RSD1046) and their amide-linked analogues (RSD996, RSD997, RSD1044).
Special emphasis was placed on a comparison of their selectivity for myocardial
ischemia-induced arrhythmias. The regional ischemia model used was ligation of
a branch of left coronary artery in anesthetized rats. Antiarrhythmic activity was
expressed as effects on incidence, severity and duration of ventricular
arrhythmias, including premature ventricular beats (PVBs), ventricular
tachycardia (VT) and ventricular fibrillation (VF). A dose-response curve for
antiarrhythmic activity was constructed by plotting the percent change in
arrhythmia score, from control value, versus log-m dose. The effective dose
producing 50% protection (ED₅₀) was calculated from the dose-response curves.
The results showed that all compounds studied were protective against ischemiainduced
arrhythmias in a dose-dependent manner. At sufficiently high doses,
these compounds completely abolished VT or VF and markedly reduced PVB.
The mortality caused by sustained VT or VF was also significantly reduced.
There were no obvious similarities in antiarrhythmic effectiveness among the
different pairs of ester and amide compounds with respect to antiarrhythmic
dose-response curves. However, antiarrhythmic dose-response curve analyses
showed that esters RSD973 and RSD1009 had antiarrhythmic effectiveness
similar to that of their corresponding amide analogues RSD996 and RSD997, respectively, in terms of efficacy, potency and curve slope. The antiarrhythmic
dose-response curve for the ester RSD1046 was parallel to that for its amide
analogue RSD1044 with a right shift (i.e. lower potency). The results suggested
that the underlying mechanisms for the antiarrhymic effects of esters and
corresponding amide analogues might be the same, although the exact
mechanisms remain unclear.
The effects of ester and amide analogues on haemodynamic and
electrocardiographic (ECG) parameters in the absence of myocardial ischemia
were investigated. In addition, electrical stimulation was applied to the heart to
examine drug effects on cardiac tissue excitability and refractoriness.
Cumulative dose-response curves were constructed and the potencies were
expressed as D₂₅values (i.e. effective dose producing 25% change from predrug
value).
Both ester and amide compounds decreased blood pressure (BP) and heart rate
(HR) in a dose-dependent manner. The ester-linked compounds were less
potent for effects on blood pressure and heart rate than their amide-linked
analogues. In most cases, a maximal response (efficacy) could not be obtained
while the slopes of dose-response curves did not differ between ester and amide
analogues.
According to their effects on the ECG and electrical stimulation variables, the
compounds could possess both sodium (Na⁺) and potassium (K⁺) channel
blocking activities. Prolongation of PR and QRS intervals of ECG, and increase
in iT and VF-VTt of electrical stimulation were considered to be mainly attributable to Na⁺ channel blockade, while prolongation of QT interval, increase
in ERP and decrease in MFF to be mainly attributable to K⁺ channel blockade.
RSD compounds influenced most of these indicators in a dose-dependent
fashion. Ester analogues appeared to be less potent for the effects on indicators
than their corresponding amide analogues, although it was not possible to
establish this conclusion statistically for all the different indicators. Comparison
(by ratios) of potencies for indicators of Na+ channel blockade (PR, iT) to those
for indicators of K⁺ channel blockade (QT, ERP) suggested no preference for Na+
or K⁺ blockade between ester and amide analogues.
Finally, in order to evaluate selectivity for antiarrhythmic effects on arrhythmias
induced by myocardial ischemia, therapeutic indices were estimated from the
ratio of D25 values for BP, HR, ECG and electrical stimulation to the ED5 0 for
antiarrhythmic activity. The morpholino esters RSD973 and RSD1009 had
higher therapeutic indices, especially for those indices related to the ECG, than
their amide analogues RSD996 and RSD997. However, for the corresponding
dimethoxy pair, RSD1046 failed to show higher therapeutic indices than its amide
analogue RSD1044, due to its lower potencies for both antiarrhythmic activity as
well as electrophysiological effects on normal cardiac tissue. Such results
suggest that the ester or amide group on morpholino compounds might be
involved in the selectivity for myocardial ischemia-induced arrhythmias through
interaction with other molecular moieties.
The tentative suggestion drawn from this study, that ester-linked compounds with
certain molecular structures provide wider safety margin with less haemodynamic depression, less bradycardiac effect and less potential proarrhythmic activity than
their amide-linked analogues, needs to be confirmed in a larger series (at least
twice the size of the present series) of structurally complementary compounds.
The underlying mechanisms of action of the esters and amides remain to be
elucidated.
|
Extent |
3511986 bytes
|
Genre | |
Type | |
File Format |
application/pdf
|
Language |
eng
|
Date Available |
2009-06-11
|
Provider |
Vancouver : University of British Columbia Library
|
Rights |
For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.
|
DOI |
10.14288/1.0088923
|
URI | |
Degree | |
Program | |
Affiliation | |
Degree Grantor |
University of British Columbia
|
Graduation Date |
1999-05
|
Campus | |
Scholarly Level |
Graduate
|
Aggregated Source Repository |
DSpace
|
Item Media
Item Citations and Data
Rights
For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.